Rob Toledo November 25, 2015
All information for Fractyl Laboratories' profile has been sourced from the PitchBook Platform. You can request a free trial here to get full access to all the information below, including valuations, funding history, investor profiles and more.
Developer of medical devices for treatment of chronic diseases. The company offers medical devices for developing therapies used in the treatment of large, complex, and costly chronic diseases. It is particularly focused on improving the health of people with Type 2 diabetes.
Below you will find Fractyl's valuation, funding history and cap tables sourced from the PitchBook Platform. Get full access to the most recent deal terms by requesting access here or logging into your PitchBook account.
Fractyl Laboratories currently has five active investors, including early stage investors General Catalyst, Bessemer Venture Partners and Domain Associates. Most recently, Deerfield Management made an investment in November 2015. See the list of investors below and get full access to their profiles by requesting a trial or logging into your PitchBook account.
Below is the contact information for the Fractyl executive team. Get full access by logging into the PitchBook Platform.
Within the PitchBook Platform, there are currently 98 Fractyl comparables listed. Get a sample list below and request trial access to see the full list.